{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:42:51Z","timestamp":1763037771790,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jaad.2022.04.029","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:47:02Z","timestamp":1650923222000},"page":"359-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bullous pemphigoid: Three main clusters defining 3 outcome profiles"],"prefix":"10.1016","volume":"87","author":[{"given":"Florine","family":"Guerrois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bettuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vannina","family":"Seta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Goulvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamia","family":"Jelti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Belmondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"Aractingi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Dupin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jaad.2022.04.029_bib1","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.029_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.029_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0625.2001.100405.x","article-title":"Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule","volume":"10","author":"Hamada","year":"2001","journal-title":"Exp Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2022.04.029_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.029_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2022.04.029_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.029_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.029_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00403-018-1817-9","article-title":"BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid","volume":"310","author":"Daneshpazhooh","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2022.04.029_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fimmu.2018.00479","article-title":"Mucosal involvement in bullous pemphigoid is mostly associated with disease severity and to absence of anti-BP230 autoantibody","volume":"9","author":"Clap\u00e9","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.029_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.029_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J Stat Soft"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.029_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v070.i01","article-title":"a package for handling missing values in multivariate data analysis","volume":"70","author":"Josse","year":"2016","journal-title":"J Stat Soft"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.029_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2340\/00015555-2848","article-title":"The Regibul Register: a tool for monitoring the distribution and incidence of autoimmune bullous dermatoses in three French regions, 2010 to 2015","volume":"98","author":"Loget","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.jaad.2022.04.029_bib14","first-page":"e219","article-title":"Bullous dermatosis involving the skin and\/or external mucosa. Article in French","volume":"69","author":"Charpentier","year":"2019","journal-title":"Rev Prat"},{"issue":"9","key":"10.1016\/j.jaad.2022.04.029_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02505245","article-title":"The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen","volume":"288","author":"Matsumura","year":"1996","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"10.1016\/j.jaad.2022.04.029_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1523-1747.1999.00501.x","article-title":"IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180","volume":"112","author":"Nie","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"suppl 12","key":"10.1016\/j.jaad.2022.04.029_bib17","doi-asserted-by":"crossref","first-page":"A73","DOI":"10.1016\/j.annder.2020.09.009","article-title":"Pemphigo\u00efde mixte muco-cutan\u00e9e: caract\u00e9ristiques cliniques et immunologiques","volume":"147","author":"Janela-Lapert","year":"2020","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.029_bib18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.029_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222006958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222006958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:02:58Z","timestamp":1759273378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222006958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0190962222006958"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.04.029","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bullous pemphigoid: Three main clusters defining 3 outcome profiles","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}